Expression of CD44 isoforms and β1,6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential

Journal of Cutaneous Pathology

Volumn 24, Issue 4, 1997, Pages 206-211

  Seelentag, Walter K F ^a   Böni, Roland ^a   Günthert, Ursula ^b   Futo, Eva ^a   Burg, Günther ^a   Heitz, Philipp U ^a   Roth, Jürgen ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; HERMES ANTIGEN; OLIGOSACCHARIDE;

ANTIGEN EXPRESSION; ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; METASTASIS; TUMOR GROWTH;

EID: 0030903512     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1997.tb01582.x     Document Type: Article

References (33)

1. Clark WH, Jr., Elder DE, Guerry D, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984: 15: 1147.
2. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970: 172: 902.
3. Soong S. A computerized mathematical model and scoring system for predicting outcome in melanoma patients. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S, eds. Cutaneous melanoma. Philadelphia: Lippincott, 1992: 200.
4. Ramsay JA, From L, Iscoe NA, Kahn HJ. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas. J Invest Dermatol 1995: 105: 22.
5. Edward M. Integrins and other adhesion molecules involved in melanocytic tumor progression [see comments]. Curr Opin Oncol 1995: 7: 185.
6. Seiter S, Arch R, Reber S, et al. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 1993: 177: 443.
7. Hofmann M, Rudy W, Zöller M, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991: 51: 5292.
8. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991: 65: 13.
9. Günthert U. CD44: a multitude of isoforms with diverse functions. Curr Topics Microbiol Immunol 1993: 184: 47.
10. Günthert U. CD44 in malignant disorders. Curr Topics Microbiol Immunol 1996: 213: 271.
11. Birch M, Mitchell SD, Hart IR. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res 1991: 51: 6660.
12. Faassen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy JB. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 1992: 116: 521.
13. Thomas L, Etoh T, Stamenkovic I, Mihm MC Jr., Byers HR. Migration of human melanoma cells on hyaluronate is related to CD44 expression. J Invest Dermatol 1993: 100: 115.
14. Guo Y, Ma J, Wang J, et al. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody [published erratum appears in Cancer Res 1994: 54(8): 2284]. Cancer Res 1994: 54: 1561.
15. van Muijen GN, Danen EH, Veerkamp JH, Ruiter DJ, Lesley J, van den Heuvel LP. Glycoconjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity. Int J Cancer 1995: 61: 241.
16. Zhang L, Underhill CB, Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 1995: 55: 428.
17. Manten Horst E, Danen EH, Smit L, et al. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 1995: 64: 182.
18. East JA, Mitchell SD, Hart IR. Expression and function of the CD44 glycoprotein in melanoma cell lines. Melanoma Res 1993: 3: 341.
19. Warren L, Buck CA, Tuszynski GP. Glycopeptide changes and malignant transformation. A possible role for carbohydrate in malignant behavior. Biochim Biophys Acta 1978: 516: 97.
20. Dennis JW, Laferte S. Oncodevelopmental expression of-GlcNAc beta 1-6Man alpha 1-6Man beta 1-branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas. Cancer Res 1989: 49: 945.
21. Li W, Zuber C, Heitz PU, Roth J. Cytochemical staining for beta 1,6 branching of asparagine-linked oligosaccharides in variants of metastatic human colon carcinoma cells. Am J Pathol 1994: 145: 470.
22. Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW. Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 1991: 51: 718.
23. Takano R, Nose M, Nishihira T, Kyogoku M. Increase of beta 1-6-branched oligosaccharides in human esophageal carcinomas invasive against surrounding tissue in vivo and in vitro. Am J Pathol 1990: 137: 1007.
24. Dennis JW, Laferte S, Vanderelst I. Asparagine-linked oligosaccharides in malignant tumour growth. Biochem Soc Trans 1989: 17: 29.
25. Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS. β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987: 236: 582.
26. Yoshimura M, Nishikawa A, Ihara Y, Taniguchi S, Taniguchi N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci USA 1995: 92: 8754.
27. Seelentag WKF, Futo E, Saremaslani P, Günthert U, Heitz PU, Roth J. CD44 standard and variant isoform expression in normal human epidermis and skin appendages. Histochem Cell Biol 1996: 106: 283.
28. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994: 124: 71.
29. Li W, Zuber C, Roth J. Use of Phaseolus vulgaris leukoag-glutinating lectin in histochemical and blotting techniques: a comparison of digoxigenin- and biotin-labeled lectins. Histochem Cell Biol 1993: 100: 347.
30. Dennis JW. N-linked oligosaccharide processing and tumor cell biology. Semin Cancer Biol 1991: 2: 411.
31. Miyoshi E, Nishikawa A, Ihara Y, et al. Transforming growth factor beta up-regulates expression of the N-acetyl-glucosaminyltransferase V gene in mouse melanoma cells. J Biol Chem 1995: 270: 6216.
32. Seelentag WKF, Günthert U, Saremaslani P, et al. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but downregulated during proliferation and tumor dedifferentiation. IntJ Cancer 1996: 69: 218.
33. Fernández-Figueras M-T, Ariza A, Calatrava A, Puig I., Fernández-Vasalo A, Ferrándiz C. CD44 and melanocytic tumors: a possible role for standard CD44 in the epidermotropic spread of melanoma. J Cutan Pathol 1966: 23: 133.